Atlanta,
Georgia
- Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C.
(www.hatchmedical.com) today announced it has signed an
agreement with physician inventor, Aubrey Palestrant, M.D. for his unique
vascular access technology consisting of four proprietary patents. Under the
terms of the agreement, Hatch Medical and Aubrey Palestrant, M.D. will create
FlatCath, L.L.C., a joint venture, to develop and market this unique vascular
access technology to the medical device industry.
Dr.
Palestrant's proprietary technology and design elements described in his
patents are intended to improve catheter patency and longevity while minimizing
vessel trauma and thrombus formation. Large,
multi-lumen catheters are regularly placed into the venous system to perform
hemodialysis, infusion or aspiration. Catheter
placement often creates turbulence and sluggish blood flow resulting in a myriad
of patient-related health concerns. Dr.
Palestrant's patents allow for a catheter design that significantly decreases
its cross-sectional dimensions within the blood vessel when the catheter is not
in use. Consequently, this unique
design reduces the likelihood of catheter-based complications resulting from
thrombus formation.
"This
unique catheter technology fits perfectly into our portfolio of vascular access
products and Hatch Medical's guiding principle to improve the lives of
patients," commented Steven Hvozda, Executive Vice President of Hatch Medical.
"Management and preservation of vascular access relies on many creative
approaches. We are convinced this
innovation will play an important role in the evolution of the next generation
of access catheters," added Mr. Hvozda.
Aubrey
Palestrant, M.D., physician and inventor commented, "Venous access is a vital
aspect of survival for many patients with chronic diseases that require long
term venous infusions or dialysis. Hatch
Medical is an ideal partner to develop this technology, as their expertise and
experience in vascular access devices is vital.
I look forward to taking an active role in the development and
commercialization of this novel technology and truly believe it will alter what
is now considered to be the standard of care in vascular access catheter
technology."
Hatch
Medical jointly develops and brokers minimally invasive medical devices for the
diagnosis and treatment of vascular and oncological disease through its network
of product development experts. Hatch
Medical team members include intellectual property and transactional attorneys,
biomedical engineers, regulatory affairs consultants, marketing and business
development executives, medical device manufacturers, university teaching
hospitals and leading physicians.
Through
Hatch Medical's unique risk-sharing program, product development team members
exchange services and resources for equity in physician conceived projects.
This structure enables the physician inventor to benefit from the
services of industry experts without paying upfront costs or out-of-pocket
expenses, while maintaining meaningful equity.
For additional information on Hatch Medical, L.L.C. products and services, e-mail the company at info@hatchmedical.com. This release and additional news about Hatch Medical can be obtained by visiting the company's web site at http://www.hatchmedical.com, contact Paul Gianneschi, President and CEO, 770-982-6306, or Steven Hvozda, Executive Vice President, Business Development 404-982-9994.
Hatch Medical,
L.L.C.
Duluth, GA 30097
Phone: 770-476-9940
Facsimile: 770-476-7740
info@hatchmedical.com
© 2001 - 2008 Hatch Medical, L.L.C. - All rights reserved